Brainstorm Cell Therapeutics Inc (BCLI) — Cash Flow-to-Debt Ratio
Brainstorm Cell Therapeutics Inc (BCLI) has a Cash Flow-to-Debt Ratio of -0.11x as of March 2026, meaning its operating cash flow of $-1.32 Million could theoretically repay 0% of its total liabilities ($11.76 Million) in one year. Explore Brainstorm Cell Therapeutics Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Brainstorm Cell Therapeutics Inc Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Brainstorm Cell Therapeutics Inc across 25 annual periods. Also explore Brainstorm Cell Therapeutics Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Brainstorm Cell Therapeutics Inc (2001–2025)
Year-by-year debt coverage analysis for Brainstorm Cell Therapeutics Inc. For market capitalisation and broader financial context, see how much is Brainstorm Cell Therapeutics Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.63x | $-6.97 Million | $11.01 Million | ▲ +33.1% |
| 2024 | -0.95x | $-9.09 Million | $9.60 Million | ▲ +58.0% |
| 2023 | -2.26x | $-20.46 Million | $9.07 Million | ▼ -33.9% |
| 2022 | -1.68x | $-19.32 Million | $11.47 Million | ▲ +36.3% |
| 2021 | -2.64x | $-26.27 Million | $9.94 Million | ▼ -18.7% |
| 2020 | -2.23x | $-35.19 Million | $15.79 Million | ▼ -271.6% |
| 2019 | -0.60x | $-11.25 Million | $18.76 Million | ▲ +69.9% |
| 2018 | -1.99x | $-12.39 Million | $6.21 Million | ▼ -367.6% |
| 2017 | -0.43x | $-2.36 Million | $5.54 Million | ▲ +93.7% |
| 2016 | -6.78x | $-5.86 Million | $864.00K | ▼ -170.2% |
| 2015 | -2.51x | $-7.41 Million | $2.95 Million | ▼ -81.0% |
| 2014 | -1.39x | $-4.49 Million | $3.24 Million | ▲ +32.0% |
| 2013 | -2.04x | $-4.05 Million | $1.99 Million | ▲ +19.1% |
| 2012 | -2.52x | $-2.92 Million | $1.16 Million | ▼ -42.5% |
| 2011 | -1.77x | $-2.22 Million | $1.26 Million | ▼ -32.4% |
| 2010 | -1.34x | $-2.07 Million | $1.55 Million | ▼ -349.1% |
| 2009 | -0.30x | $-744.00K | $2.50 Million | ▲ +49.4% |
| 2008 | -0.59x | $-1.73 Million | $2.95 Million | ▼ -16.3% |
| 2007 | -0.51x | $-1.77 Million | $3.51 Million | ▼ -50.0% |
| 2006 | -0.34x | $-855.00K | $2.54 Million | ▼ -135.9% |
| 2005 | -0.14x | $-1.25 Million | $8.77 Million | ▲ +96.3% |
| 2004 | -3.87x | $-677.84K | $174.95K | ▼ -1096.4% |
| 2003 | -0.32x | $-15.44K | $47.67K | ▼ -16.0% |
| 2002 | -0.28x | $-7.01K | $25.13K | ▲ +56.9% |
| 2001 | -0.65x | $-7.44K | $11.49K | — |